60 related articles for article (PubMed ID: 11846354)
1. A survey of diagnosis, management, and grading of chronic GVHD.
Lee SJ; Vogelsang G; Gilman A; Weisdorf DJ; Pavletic S; Antin JH; Horowitz MM; Akpek G; Flowers ME; Couriel D; Martin PJ
Biol Blood Marrow Transplant; 2002; 8(1):32-9. PubMed ID: 11846354
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD.
Hildebrandt GC; Fazekas T; Lawitschka A; Bertz H; Greinix H; Halter J; Pavletic SZ; Holler E; Wolff D
Bone Marrow Transplant; 2011 Oct; 46(10):1283-95. PubMed ID: 21441964
[TBL] [Abstract][Full Text] [Related]
3. The treatment of chronic graft-versus-host disease: consensus recommendations of experts from Germany, Austria, and Switzerland.
Wolff D; Bertz H; Greinix H; Lawitschka A; Halter J; Holler E
Dtsch Arztebl Int; 2011 Oct; 108(43):732-40. PubMed ID: 22114649
[TBL] [Abstract][Full Text] [Related]
4. The graft-versus-leukemia effect of prophylactic donor lymphocyte infusions after allogeneic stem cell transplantation is equally effective in relapse prevention but safer compared to spontaneous graft-versus-host disease.
Stadler M; Hambach L; Dammann E; Diedrich H; Kamal H; Hamwi I; Schultze-Florey C; Varvenne M; Ehrlich S; Buchholz S; Koenecke C; Beutel G; Weissinger EM; Krauter J; Eder M; Hertenstein B; Ganser A
Ann Hematol; 2023 Sep; 102(9):2529-2542. PubMed ID: 37490114
[TBL] [Abstract][Full Text] [Related]
5. Inpatient Management of Mucocutaneous GVHD.
Vaidya T; Menzer C; Ponce DM; Markova A
Curr Dermatol Rep; 2019 Dec; 8(4):258-278. PubMed ID: 33312761
[TBL] [Abstract][Full Text] [Related]
6. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.
Zhou Z; Nath R; Cerny J; Wang HL; Zhang MJ; Abdel-Azim H; Agrawal V; Ahmed G; Al-Homsi AS; Aljurf M; Alkhateeb HB; Assal A; Bacher U; Bajel A; Bashir Q; Battiwalla M; Bhatt VR; Byrne M; Cahn JY; Cairo M; Choe H; Copelan E; Cutler C; Damlaj MB; DeFilipp Z; De Lima M; Diaz MA; Farhadfar N; Foran J; Freytes CO; Gerds AT; Gergis U; Grunwald MR; Gul Z; Hamadani M; Hashmi S; Hertzberg M; Hildebrandt GC; Hossain N; Inamoto Y; Isola L; Jain T; Kamble RT; Khan MW; Kharfan-Dabaja MA; Kebriaei P; Kekre N; Khera N; Lazarus HM; Liesveld JL; Litzow M; Liu H; Marks DI; Martino R; Mathews V; Mishra A; Murthy HS; Nagler A; Nakamura R; Nathan S; Nishihori T; Olin R; Olsson RF; Palmisiano N; Patel SS; Patnaik MM; Pawarode A; Perales MA; Politikos I; Popat U; Rizzieri D; Sandmaier BM; Savani BN; Seo S; Shah NN; Uy GL; Valcárcel D; Verdonck LF; Waller EK; Wang Y; Weisdorf D; Wirk B; Wong E; Yared JA; Saber W
Blood Adv; 2020 Jul; 4(13):3180-3190. PubMed ID: 32663298
[TBL] [Abstract][Full Text] [Related]
7. Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria.
Cuvelier GDE; Nemecek ER; Wahlstrom JT; Kitko CL; Lewis VA; Schechter T; Jacobsohn DA; Harris AC; Pulsipher MA; Bittencourt H; Choi SW; Caywood EH; Kasow KA; Bhatia M; Oshrine BR; Flower A; Chaudhury S; Coulter D; Chewning JH; Joyce M; Savaşan S; Pawlowska AB; Megason GC; Mitchell D; Cheerva AC; Lawitschka A; West LJ; Pan B; Al Hamarneh YN; Halevy A; Schultz KR
Blood; 2019 Jul; 134(3):304-316. PubMed ID: 31043425
[TBL] [Abstract][Full Text] [Related]
8. EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment.
Schoemans HM; Lee SJ; Ferrara JL; Wolff D; Levine JE; Schultz KR; Shaw BE; Flowers ME; Ruutu T; Greinix H; Holler E; Basak G; Duarte RF; Pavletic SZ;
Bone Marrow Transplant; 2018 Nov; 53(11):1401-1415. PubMed ID: 29872128
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin and resistin in acute and chronic graft-vs-host disease patients undergoing allogeneic hematopoietic stem cell transplantation.
Robak O; Kuzmina Z; Winkler A; Kalhs P; Rabitsch W; Greinix H
Croat Med J; 2016 Jun; 57(3):255-65. PubMed ID: 27374827
[TBL] [Abstract][Full Text] [Related]
10. Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.
Ghosh N; Karmali R; Rocha V; Ahn KW; DiGilio A; Hari PN; Bachanova V; Bacher U; Dahi P; de Lima M; D'Souza A; Fenske TS; Ganguly S; Kharfan-Dabaja MA; Prestidge TD; Savani BN; Smith SM; Sureda AM; Waller EK; Jaglowski S; Herrera AF; Armand P; Salit RB; Wagner-Johnston ND; Fuchs E; Bolaños-Meade J; Hamadani M
J Clin Oncol; 2016 Sep; 34(26):3141-9. PubMed ID: 27269951
[TBL] [Abstract][Full Text] [Related]
11. Next-generation long-term transplant clinics: improving resource utilization and the quality of care through health information technology.
Rioth MJ; Warner J; Savani BN; Jagasia M
Bone Marrow Transplant; 2016 Jan; 51(1):34-40. PubMed ID: 26367235
[TBL] [Abstract][Full Text] [Related]
12. Uptake and use of recommendations for the diagnosis, severity scoring and management of chronic GVHD: an international survey of the EBMT-NCI Chronic GVHD Task Force.
Duarte RF; Greinix H; Rabin B; Mitchell SA; Basak G; Wolff D; Madrigal JA; Pavletic SZ; Lee SJ
Bone Marrow Transplant; 2014 Jan; 49(1):49-54. PubMed ID: 23955633
[TBL] [Abstract][Full Text] [Related]
13. Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease.
Inamoto Y; Storer BE; Lee SJ; Carpenter PA; Sandmaier BM; Flowers ME; Martin PJ
Blood; 2013 Mar; 121(12):2340-6. PubMed ID: 23321253
[TBL] [Abstract][Full Text] [Related]
14. A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant.
Khaled SK; Palmer J; Stiller T; Senitzer D; Maegawa R; Rodriguez R; Parker PM; Nademanee A; Cai JL; Snyder DS; Karanes C; Osorio E; Thomas SH; Forman SJ; Nakamura R
Bone Marrow Transplant; 2013 Feb; 48(2):278-83. PubMed ID: 23000644
[TBL] [Abstract][Full Text] [Related]
15. Clinical Results of Extracorporeal Photopheresis.
Worel N; Leitner G
Transfus Med Hemother; 2012 Aug; 39(4):254-262. PubMed ID: 22969695
[TBL] [Abstract][Full Text] [Related]
16. Treatment of chronic graft-versus-host disease: Past, present and future.
Martin PJ; Inamoto Y; Carpenter PA; Lee SJ; Flowers ME
Korean J Hematol; 2011 Sep; 46(3):153-63. PubMed ID: 22065969
[TBL] [Abstract][Full Text] [Related]
17. Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research.
Mahindra A; Kalaycio ME; Vela-Ojeda J; Vesole DH; Zhang MJ; Li P; Berenson JR; Bird JM; Dispenzieri A; Gajewski JL; Gale RP; Holmberg L; Kumar S; Kyle RA; Lazarus HM; Lonial S; Mikhael J; Milone GA; Munker R; Nath R; Saccaro S; To LB; Vogl DT; Wirk B; Hari P
Leukemia; 2012 May; 26(5):1091-7. PubMed ID: 22042147
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients.
Kreisel W; Dahlberg M; Bertz H; Harder J; Potthoff K; Deibert P; Schmitt-Graeff A; Finke J
Bone Marrow Transplant; 2012 Mar; 47(3):430-8. PubMed ID: 21706064
[TBL] [Abstract][Full Text] [Related]
19. Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan.
Iida M; Fukuda T; Ikegame K; Yoshihara S; Ogawa H; Taniguchi S; Takami A; Abe Y; Hino M; Etou T; Ueda Y; Yujiri T; Matsui T; Okamura A; Tanaka J; Atsuta Y; Kodera Y; Suzuki R
Int J Hematol; 2011 Apr; 93(4):523-531. PubMed ID: 21465117
[TBL] [Abstract][Full Text] [Related]
20. Variation in management of immune suppression after allogeneic hematopoietic cell transplantation.
Pidala J; Lee SJ; Quinn G; Jim H; Kim J; Anasetti C
Biol Blood Marrow Transplant; 2011 Oct; 17(10):1528-36. PubMed ID: 21440079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
